Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis

JoAnn M. Tufariello, Kaixia Mi, Jiayong Xu, Yukari C. Manabe, Anup K. Kesavan, Joshua Drumm, Kathryn E. Tanaka, William R. Jacobs, John Chan

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Approximately one-third of the human population is latently infected with Mycobacterium tuberculosis, comprising a critical reservoir for disease reactivation. Despite the importance of latency in maintaining M. tuberculosis in the human population, little is known about the mycobacterial factors that regulate persistence and reactivation. Previous in vitro studies have implicated a family of five related M. tuberculosis proteins, called resuscitation promoting factors (Rpfs), in regulating mycobacterial growth. We studied the in vivo role of M. tuberculosis rpf genes in an established mouse model of M. tuberculosis persistence and reactivation. After an aerosol infection with the M. tuberculosis Erdman wild type (Erdman) or single-deletion rpf mutants to establish chronic infections in mice, reactivation was induced by administration of the nitric oxide (NO) synthase inhibitor aminoguanidine. Of the five rpf deletion mutants tested, one (ΔRv1009) exhibited a delayed reactivation phenotype, manifested by delayed postreactivation growth kinetics and prolonged median survival times among infected animals. Immunophenotypic analysis suggested differences in pulmonary B-cell responses between Erdman- and ΔRv1009-infected mice at advanced stages of reactivation. Analysis of rpf gene expression in the lungs of Erdman-infected mice revealed that relative expression of four of the five rpf-like genes was diminished at late times following reactivation, when bacterial numbers had increased substantially, suggesting that rpf gene expression may be regulated in a growth phase-dependent manner. To our knowledge, ΔRv1009 is the first M. tuberculosis mutant to have a specific defect in reactivation without accompanying growth defects in vitro or during acute infection in vivo.

Original languageEnglish (US)
Pages (from-to)2985-2995
Number of pages11
JournalInfection and Immunity
Volume74
Issue number5
DOIs
StatePublished - May 2006

Fingerprint

Mycobacterium tuberculosis
Resuscitation
Tuberculosis
Genes
Growth
Disease Reservoirs
Infection
Gene Expression
Lung
Aerosols
Nitric Oxide Synthase
Population
B-Lymphocytes
Phenotype
Survival
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. / Tufariello, JoAnn M.; Mi, Kaixia; Xu, Jiayong; Manabe, Yukari C.; Kesavan, Anup K.; Drumm, Joshua; Tanaka, Kathryn E.; Jacobs, William R.; Chan, John.

In: Infection and Immunity, Vol. 74, No. 5, 05.2006, p. 2985-2995.

Research output: Contribution to journalArticle

Tufariello, JoAnn M. ; Mi, Kaixia ; Xu, Jiayong ; Manabe, Yukari C. ; Kesavan, Anup K. ; Drumm, Joshua ; Tanaka, Kathryn E. ; Jacobs, William R. ; Chan, John. / Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis. In: Infection and Immunity. 2006 ; Vol. 74, No. 5. pp. 2985-2995.
@article{09efe6f957f64d45b5499ae50b451ae4,
title = "Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis",
abstract = "Approximately one-third of the human population is latently infected with Mycobacterium tuberculosis, comprising a critical reservoir for disease reactivation. Despite the importance of latency in maintaining M. tuberculosis in the human population, little is known about the mycobacterial factors that regulate persistence and reactivation. Previous in vitro studies have implicated a family of five related M. tuberculosis proteins, called resuscitation promoting factors (Rpfs), in regulating mycobacterial growth. We studied the in vivo role of M. tuberculosis rpf genes in an established mouse model of M. tuberculosis persistence and reactivation. After an aerosol infection with the M. tuberculosis Erdman wild type (Erdman) or single-deletion rpf mutants to establish chronic infections in mice, reactivation was induced by administration of the nitric oxide (NO) synthase inhibitor aminoguanidine. Of the five rpf deletion mutants tested, one (ΔRv1009) exhibited a delayed reactivation phenotype, manifested by delayed postreactivation growth kinetics and prolonged median survival times among infected animals. Immunophenotypic analysis suggested differences in pulmonary B-cell responses between Erdman- and ΔRv1009-infected mice at advanced stages of reactivation. Analysis of rpf gene expression in the lungs of Erdman-infected mice revealed that relative expression of four of the five rpf-like genes was diminished at late times following reactivation, when bacterial numbers had increased substantially, suggesting that rpf gene expression may be regulated in a growth phase-dependent manner. To our knowledge, ΔRv1009 is the first M. tuberculosis mutant to have a specific defect in reactivation without accompanying growth defects in vitro or during acute infection in vivo.",
author = "Tufariello, {JoAnn M.} and Kaixia Mi and Jiayong Xu and Manabe, {Yukari C.} and Kesavan, {Anup K.} and Joshua Drumm and Tanaka, {Kathryn E.} and Jacobs, {William R.} and John Chan",
year = "2006",
month = "5",
doi = "10.1128/IAI.74.5.2985-2995.2006",
language = "English (US)",
volume = "74",
pages = "2985--2995",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis

AU - Tufariello, JoAnn M.

AU - Mi, Kaixia

AU - Xu, Jiayong

AU - Manabe, Yukari C.

AU - Kesavan, Anup K.

AU - Drumm, Joshua

AU - Tanaka, Kathryn E.

AU - Jacobs, William R.

AU - Chan, John

PY - 2006/5

Y1 - 2006/5

N2 - Approximately one-third of the human population is latently infected with Mycobacterium tuberculosis, comprising a critical reservoir for disease reactivation. Despite the importance of latency in maintaining M. tuberculosis in the human population, little is known about the mycobacterial factors that regulate persistence and reactivation. Previous in vitro studies have implicated a family of five related M. tuberculosis proteins, called resuscitation promoting factors (Rpfs), in regulating mycobacterial growth. We studied the in vivo role of M. tuberculosis rpf genes in an established mouse model of M. tuberculosis persistence and reactivation. After an aerosol infection with the M. tuberculosis Erdman wild type (Erdman) or single-deletion rpf mutants to establish chronic infections in mice, reactivation was induced by administration of the nitric oxide (NO) synthase inhibitor aminoguanidine. Of the five rpf deletion mutants tested, one (ΔRv1009) exhibited a delayed reactivation phenotype, manifested by delayed postreactivation growth kinetics and prolonged median survival times among infected animals. Immunophenotypic analysis suggested differences in pulmonary B-cell responses between Erdman- and ΔRv1009-infected mice at advanced stages of reactivation. Analysis of rpf gene expression in the lungs of Erdman-infected mice revealed that relative expression of four of the five rpf-like genes was diminished at late times following reactivation, when bacterial numbers had increased substantially, suggesting that rpf gene expression may be regulated in a growth phase-dependent manner. To our knowledge, ΔRv1009 is the first M. tuberculosis mutant to have a specific defect in reactivation without accompanying growth defects in vitro or during acute infection in vivo.

AB - Approximately one-third of the human population is latently infected with Mycobacterium tuberculosis, comprising a critical reservoir for disease reactivation. Despite the importance of latency in maintaining M. tuberculosis in the human population, little is known about the mycobacterial factors that regulate persistence and reactivation. Previous in vitro studies have implicated a family of five related M. tuberculosis proteins, called resuscitation promoting factors (Rpfs), in regulating mycobacterial growth. We studied the in vivo role of M. tuberculosis rpf genes in an established mouse model of M. tuberculosis persistence and reactivation. After an aerosol infection with the M. tuberculosis Erdman wild type (Erdman) or single-deletion rpf mutants to establish chronic infections in mice, reactivation was induced by administration of the nitric oxide (NO) synthase inhibitor aminoguanidine. Of the five rpf deletion mutants tested, one (ΔRv1009) exhibited a delayed reactivation phenotype, manifested by delayed postreactivation growth kinetics and prolonged median survival times among infected animals. Immunophenotypic analysis suggested differences in pulmonary B-cell responses between Erdman- and ΔRv1009-infected mice at advanced stages of reactivation. Analysis of rpf gene expression in the lungs of Erdman-infected mice revealed that relative expression of four of the five rpf-like genes was diminished at late times following reactivation, when bacterial numbers had increased substantially, suggesting that rpf gene expression may be regulated in a growth phase-dependent manner. To our knowledge, ΔRv1009 is the first M. tuberculosis mutant to have a specific defect in reactivation without accompanying growth defects in vitro or during acute infection in vivo.

UR - http://www.scopus.com/inward/record.url?scp=33646372958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646372958&partnerID=8YFLogxK

U2 - 10.1128/IAI.74.5.2985-2995.2006

DO - 10.1128/IAI.74.5.2985-2995.2006

M3 - Article

VL - 74

SP - 2985

EP - 2995

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 5

ER -